GynecologyGynecology2079-56962079-5831Consilium Medicum6373910.26442/20795696.2021.1.200647Research ArticleComparison of the results of clinical and morphological methods of research in HPV-associated diseases of the cervix (retrospective study)AttoevaDjamilya I.<p>Graduate Student</p>attoevadjamilya@gmail.comAsaturovaAlexandra V.<p>D. Sci. (Med.)</p>grab2@yandex.ruPrilepskayaVera N.<p>D. Sci. (Med.), Prof.</p>v_prilepskaya@oparina4.ruStarodubtsevaNataliia L.<p>Cand. Sci. (Biol.)</p>n_starodubtseva@oparina4.ruSheshkoPolina L.<p>oncologist, obstetrician-gynecologist</p>Dr.sheshko@gmail.comhttps://orcid.org/0000-0003-3905-8026UruymagovaAda T.<p>Graduate Student</p>ada.uruimagova@yandex.ruKulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology1502202123178822003202120032021Copyright © 2021, Consilium Medicum2021<p><strong>Aim. </strong>To conduct a retrospective analysis and evaluate the morphological methods for HPV-related intraepithelial lesions detection in women of reproductive age.</p>
<p><strong>Materials and methods. </strong>The data of cytological diagnosis, as well as the results of histological reports were analyzed for the period from 2018 to 2019. A comparative analysis was performed in 415 patients with HPV-related intraepithelial lesions, who applied to the scientific and polyclinic department of the Kulakov National Research Medical Center at the age of 19 to 45 years. Morphological examination was carried out by specialists of the 1st pathology department of the Center.</p>
<p><strong>Results. </strong>According to the results of a comparative analysis of cytological and histological conclusions, 3 groups were formed: 1 the group of coincidence (agree) of cytological and histological conclusions; 2 group of minor discrepancies (minor under/ over) between cytological and histological finding; 3 group of major discrepancies (major under/ over) between cytological and histological findings. Cytological and histological compliance was achieved in 194 (46.74%) patients. The total number of minor nonconformities was 192 (46%) cases. The total number of significant discrepancies between cytological and histological findings was 29 (6.9%) patients: 20 (4.8%) cases were found in the group NILM, hr. cervicitis HSIL and 9 (2.1%) cases in the group HSIL hr. cervicitis according to the results of histological examination.</p>
<p><strong>Conclusion. </strong>Cervical screening reduces the risk of breast cancer due to cytological examination of the cervix, but histological examination is crucial in making a correct diagnosis, since its result determines the choice of treatment method. The comparative analysis showed that in all groups there were cases of hypo- and hyperdiagnostics during cytological examination although the major discrepancies which can change treatment algorithm, were found only in 6.8% cases.</p>cervical intraepithelial lesionsNILMASC-USLSILHSILcytological examinationhistological diagnosiscytology-histology correlationплоскоклеточное интраэпителиальное поражение шейки матки тяжелой степенирак шейки маткицервицитцитологиягистологическое исследование[Stewart BW, Wild CP. World Cancer Report. Lyon: International Agency for Research on Cancer, World Health Organization, 2014.][Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2016 году (заболеваемость и смертность). М.: ФГУ МНИОИ им. П.А. Герцена; 2018 [Kaprin A.D., Starinskii V.V., Petrova G.V. Malignant neoplasms in Russia in 2016 (morbidity and mortality). Moscow, 2018 (in Russian)].][WHO/ICO Information Centre on HPV and Cancer. Russian Federation: Human Papillomavirus and Related Cancers, Fact Sheet 2016. Available at: http://www.hpvcentre.net. Accessed: 15.12.2016.][Sasieni PD. Int J Cancer 2009; 124: 461–4. DOI: 10.1111/1471-0528.13719][Sodhani P, Singh V, Das DK, Bhambhani S. Cytohistological correlation as a measure of quality assurance of a cytology laboratory. Cytopathology 1997; 8: 103–7.][Crasta JA, Chaitra V, Simi CM, Correa M. An audit of cervicovaginal cytology in a teaching hospital: are atypical glandular cells under-recognised on cytological screening? J Cytol 2009; 26: 69–73.][Alanbay I, Öztürk M, Fıratlıgil FB, et al. Cytohistological discrepancies of cervico-vaginal smears and HPV status. Ginekol Pol 2017; 88: 235–8.][Crothers BA, Jones BA, Cahill LA, et al. Quality improvement opportunities in gynecologic cytologic-histologic correlations: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 4. Arch Pathol Lab Med 2013; 137 (2): 199–213. DOI: 10.5858/arpa.2012-0250-OA; PMID: 23368862][Gupta R, Hariprasad R, Dhanasekaran K, et al. Reappraisal of cytology-histology correlation in cervical cytology based on the recent American Society of Cytopathology guidelines (2017) at a cancer research centre. Cytopathology 2020; 31: 53–8. DOI: 10.1111/cyt.12774][Joste NE, Crum CP, Cibas ES. Cytologic/histologic correlation for quality control in cervicovaginal cytology. Experience with 1,582 paired cases. Am J Clin Pathol 1995; 103 (1): 32–4. DOI: 10.1093/ajcp/103.1.32][Sritipsukho P, Thaweekul Y. Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: a systematic review. J Med Assoc Thai 2010; 93 (Suppl. 7): S254–61.][Bergeron C, von Knebel Doeberitz M. The Role of Cytology in the 21st Century: The Integration of Cells and Molecules. Acta Cytol 2016; 60 (6): 540–2. DOI: 10.1159/000449402][Chen C, Yang Z, Li Z, Li L. Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis. Int J Gynecol Cancer 2012; 22 (6): 908–21. DOI: 10.1097/IGC.0b013e318256e5e4][Monsonego J. Prevention of cervical cancer: screening, progress and perspectives. Presse Med 2007; 36 (1 pt. 2): 92–111.][Katki HA, Schiffman M, Castle PE, et al. Fiveyear risk of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. J Low Genit Tract Dis 2013; 17: 36–42.][Ciavattini A, Clemente N, Tsiroglou D, et al. Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be? Arch Gynecol Obstet 2017; 295 (4): 997–1003. DOI: 10.1007/s00404-017-4335-7][Arbyn M, Xu L, Verdoodt F, et al. Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis. Ann Intern Med 2017; 166 (2): 118–27.][Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasiagrade 2. Obstet Gynecol 2009; 113 (1): 18–25.][Reuschenbach M, Wentzensen N, Dijkstra MG, et al. p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement. Am J Clin Pathol 2014; 142 (6): 767–72. DOI: 10.1309/AJCP3TPHV4TRIZEK][Gurrola-Díaz CM, Suárez-Rincón AE, Vázquez-Camacho G, et al. P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies. Gynecol Oncol 2008; 111 (1): 120–4. DOI: 10.1016/j.ygyno.2008.06.032][Короленкова Л.И. Цервикальные траэпителиальные неоплазии и ранние формы рака шейки матки: клинико-морфологическая концепция цервикального канцерогенеза. М., 2017 [Korolenkova L.I. Cervical traepithelial neoplasias and early forms of cervical cancer: clinical and morphological concept of cervical carcinogenesis. Moscow, 2017 (in Russian)].][Короленкова Л.И., Ермилова В.Д. Зона трансформации шейки матки как объект канцерогенного действия вирусов папилломы человека при возникновении CIN и инвазивного рака – отражение в клинике. Архив патологии. 2011; 73 (6): 33–7 [Korolenkova L.I., Ermilova V.D. Zona transformatsii sheiki matki kak ob»ekt kantserogennogo deistviia virusov papillomy cheloveka pri vozniknovenii CIN i invazivnogo raka – otrazhenie v klinike. Arkhiv patologii. 2011; 73 (6): 33–7 (in Russian)].][Nilsson K, Norberg C, Mossberg AK, Schwartz S. HPV16 E5 is produced from an HPV16 early mRNA spliced from SD226 to SA3358. Virus Res 2017; 244: 128–36.][Некрасова М.Е., Стародубцева Н.Л., Чаговец В.В. и др. Липидомика: новые перспективы поиска маркеров неоплазий. Акушерство и гинекология. 2017; 3: 34–40 [Nekrasova M.E., Starodubtseva N.L., Chagovets V.V. et al. Lipidomika: novye perspektivy poiska markerov neoplazii. Akusherstvo i ginekologiia. 2017; 3: 34–40 (in Russian)].][Tokareva AO, Chagovets VV, Starodubtseva NL, et al. Feature selection for OPLS-DA discriminant analysis of cancer tissue lipidomics data. JMS 2019. DOI: 10.1002/jms.4457]